Status:
UNKNOWN
Effect of Thyrotropin Level on Iodine Uptake in Metastatic Differentiated Thyroid Cancer
Lead Sponsor:
Peking Union Medical College Hospital
Collaborating Sponsors:
Peking University Cancer Hospital & Institute
Conditions:
Differentiated Thyroid Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Distant metastases is the leading cause of differentiated thyroid cancer-related death. Radioactive iodine (RAI) treatment is the most effective therapy for RAI-avid metastatic differentiated thyroid ...
Detailed Description
It is estimated that 10 patients who met the study criteria will be enrolled. All patients underwent twice 124I PET/CT scans in Beijing Cancer Hospital. The first 124I PET/CT was prepared with endogen...
Eligibility Criteria
Inclusion
- Patients underwent total thyroidectomy.
- Patients were diagnosed with differentiated thyroid cancer by postoperative pathological examination.
- Distant metastases confirmed by CT etc.
Exclusion
- Pregnancy or lactation.
- Significant hepatic or renal dysfunction;
- Unable to lie flat, still or tolerate a PET scan.
Key Trial Info
Start Date :
May 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04880798
Start Date
May 6 2021
End Date
December 31 2022
Last Update
May 11 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730
2
Beijing Cancer Hospital
Beijing, China